Mutational screening of SF1 and WNT4 in Tunisian women with premature ovarian failure

Gene

Volumn 509, Issue 2, 2012, Pages 298-301

  Lakhal, Besma ^a   Ben Hadj Khalifa, Sonia ^b   Bouali, Nouha ^a   Philipert, Pascal ^c   Audran, Françoise ^c   Braham, Rim ^a   Hatem, Elghezal ^a   Sultan, Charles ^c   Saad, Ali ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c LAPEYRONIE HOSPITAL   (France)

Author keywords

Polymorphism; Premature ovarian failure; Risk factor; SF1; WNT4

Indexed keywords

ESTRADIOL; GENOMIC DNA; STEROIDOGENIC FACTOR 1; TESTOSTERONE; WNT4 PROTEIN;

ADULT; AMENORRHEA; ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PATHOGENESIS; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; TUNISIA;

ADULT; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; HUMANS; MUTATION; POLYMORPHISM, GENETIC; PRIMARY OVARIAN INSUFFICIENCY; STEROIDOGENIC FACTOR 1; TUNISIA; WNT4 PROTEIN;

EID: 84866353260     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.08.007     Document Type: Article

References (46)

1. Biason-Lauber A., De Filippo G., Konrad D., Scarano G., Nazzaro A., Schoenle E.J. WNT4 deficiency-a clinical phenotype distinct from the classic Mayer-Rokitansky-Kuster-Hauser syndrome: a case report. Hum. Reprod. 2007, 22:224-229.
2. Bodega B., et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum. Reprod. 2006, 21:952-957.
3. Chen B., et al. Mutation analysis of the WNT4 gene in Han Chinese women with premature ovarian failure. Reprod. Biol. Endocrinol. 2011, 9:75.
4. Christin-Maitre S., Ronci-Chaix N., Bouchard P. Ovary genes and molecular pathology. J. Soc. Biol. 2002, 196:207-216.
5. Clemens J.W., Lala D.S., Parker K.L., Richards J.S. Steroidogenic factor-1 binding and transcriptional activity of the cholesterol side-chain cleavage enzyme promoter in rat granulosa cells. Endocrinology 1994, 134:1499-1508.
6. Conway G.S. Premature ovarian failure. Br. Med. Bull. 2000, 56:643-649.
7. Coulam C., Adamson S.C., Annegers J.F. Incidence of premature ovarian failure. Obstet. Gynecol. 1986, 67:604-606.
8. Crisponi L., Deiana M., Loi A., Chiappe F., Uda M., Amati P. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat. Genet. 2001, 27:159-166.
9. Dajee M., Fey G.H., Richards J.S. Stat 5b and the orphan nuclear receptors regulate expression of the alpha2-macroglobulin (alpha2M) gene in rat ovarian granulosa cells. Mol. Endocrinol. 1998, 12:1393-1409.
10. Fitzpatrick S.L., Richards J.S. Cis-acting elements of the rat aromatase promoter required for cyclic adenosine 3', 5'-monophosphate induction in ovarian granulosa cells and constitutive expression in R2C Leydig cells. Mol. Endocrinol. 1993, 7:341-354.
11. Gurates B., et al. WT1 and DAX-1 regulate SF-1-mediated human P450arom gene expression in gonadal cells. Mol. Cell. Endocrinol. 2003, 208:61-75.
12. Hanley N.A., Rainey W.E., Wilson D.I., Ball S.G., Parker K.L. Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential interactions in gene regulation. Mol. Endocrinol. 2001, 15:57-68.
13. Hatano O., et al. Sex-dependent expression of a transcription factor, Ad4BP, regulating steroidogenic P-450 genes in the gonads during prenatal and postnatal rat development. Development 1994, 120:2787-2797.
14. Hoek A., Schoemaker J., Drexhage H.A. Premature ovarian failure and ovarian autoimmunity. Endocrinol. Rev. 1997, 18:107-134.
15. Ikeda Y., Shen W.-H., Ingraham H.A., Parker K.L. Developmental expression of mouse steroidogenic factor 1, an essential regulator of the steroid hydroxylases. Mol. Endocrinol. 1994, 8:654-662.
16. Jaaskelainen M., et al. WNT4 is expressed in human fetal and adult ovaries and its signaling contributes to ovarian cell survival. Mol. Cell. Endocrinol. 2010, 317:106-111.
17. Jeyasuria P., et al. Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol. Endocrinol. 2004, 18:1610-1619.
18. Keri R.A., Nilson J.H. A steroidogenic factor-1 binding site is required for activity of the luteinizing hormone beta subunit promoter in gonadotropes of transgenic mice. J. Biol. Chem. 1996, 271:10782-11095.
19. Laissue P., Vinci G., Veitia R.A., Fellous M. Recent advances in the study of genes involved in non-syndromic premature ovarian failure. Mol. Cell. Endocrinol. 2008, 282(1-2):101-111.
20. Lakhal B., et al. A novel BMP15 variant, potentially affecting the signal peptide, in a familial case of premature ovarian failure. Clin. Endocrinol. 2009, 71:752-755.
21. Lavorgna G., Ueda H., Clos J., Wu C. FTZ-F1. A steroid hormone receptor-like protein implicated in the activation of fushi tarazu. Science 1991, 252:848-851.
22. 4 isomerase promoter by the transcription factor adrenal 4-binding protein/steroidogenic factor-1. J. Biol. Chem. 1997, 272:7960-7967.
23. Lin L., Achermann J.C. Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex. Dev. 2008, 2:200-209.
24. Lourenço D., et al. Mutations in NR5A1 associated with ovarian insufficiency. N. Engl. J. Med. 2009, 360(12):1200-1210.
25. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell 1994, 77:481-490.
26. Mandel H., et al. SERKAL syndrome: an autosomal-recessive disorder caused by a loss-of-function mutation in WNT4. Am. J. Hum. Genet. 2008, 82:39-47.
27. Mendelson C.R., Kamat A. Mechanisms in the regulation of aromatase in developing ovary and placenta. J. Steroid Biochem. Mol. Biol. 2007, 106:62-70.
28. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1998, 16:1215.
29. Morohashi K.I., Omura T. Ad4PB/SF-1, a transcription factor essential for the transcription of steroidogenic cytochrome P450 genes and for establishment of the reproductive function. FASEB J. 1996, 10:1569-1577.
30. Perez G.I., Knudson C.M., Leykin L., Korsmeyer S.J., Tilly J.L. Apoptosis associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat. Med. 1997, 3:1228-1232.
31. Philibert P., et al. Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and Mullerian duct abnormalities: a French collaborative study. J. Clin. Endocrinol. Metab. 2008, 93:895-900.
32. Qin Y., Choi Y., Zhao H., Simpson J.L., Chen Z.J., Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am. J. Hum. Genet. 2000, 8(3):576-581.
33. Reinhart A.J., Williams S.C., Clark B.J., Stocco D.M. SF-1 (steroidogenic factor-1) and C/EBP beta (CCAAT/enhancer binding protein-beta) cooperate to regulate the murine StAR (steroidogenic acute regulatory) promoter. Mol. Endocrinol. 1999, 13:729-741.
34. Santoro N. Mechanisms of premature ovarian failure. Ann. Endocrinol. 2003, 64:87-92.
35. Shen W.H., Moore C.C.D., Ikeda Y., Parker K.L., Ingraham H.A. Nuclear receptor steroidogenic factor 1 regulates the Mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 1994, 77:651-661.
36. Sugawara T., Kiriakidou M., McAllister J.M., Kallen C.B., Strauss J.F. Multiple steroidogenic factor 1 binding elements in the human steroidogenic acute regulatory protein gene 5'-flanking region are required for maximal promoter activity and cyclic AMP responsiveness. Biochemistry 1997, 36:7249-7255.
37. Takamaya K., et al. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J. Clin. Endocrinol. Metab. 1995, 80:2815-2821.
38. Vainio S., Heikkila M., Kispert A., Chin N., Mc Mahon A.P. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999, 397:405-409.
39. Wada Y., Okada M., Hasegawa T., Ogata T. Association of severe micropenis with Gly146Ala polymorphism in the gene for steroidogenic factor-1. Endocr. J. 2005, 52:445-448.
40. Wada Y., Okada M., Fukami M., Sasagawa I., Ogata T. Association of cryptorchidism with Gly 146Ala polymorphism in the gene for steroidogenic factor-1. Fertil. Steril. 2006, 85:787-789.
41. Weck J., Mayo K.E. Switching of NR5A proteins associated with the inhibin alpha-subunit gene promoter after activation of the gene in granulosa cells. Mol. Endocrinol. 2006, 20:1090-1103.
42. Wehrenberg U., Ivell R., Jansen M., Von Goedecke S., Walther N. Two orphan receptors binding to a common site are involved in the regulation of the oxytocin gene in the bovine ovary. Proc. Natl. Acad. Sci. 1994, 91:1440-1444.
43. Wei L., Min L., Wu Qiang F., Hajime N., Toshihiko Y. The Gly146Ala variation in human SF-1 gene: its association with insulin resistance and type 2 diabetes in Chinese. Diabetes 2006, 3526:1-7.
44. Wu Qiang F., et al. Functional characterization of a new human Ad4BP/SF-1 variation, G146A. Biochem. Biophys. Res. Commun. 2003, 311:987-994.
45. Yao H.H., et al. Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev. Dyn. 2004, 230:210-215.
46. Zhao H., et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am. J. Hum. Genet. 2008, 82(6):1342-1348.